Recent Headlines
Within Health Care Products
American Standard Circuits Acquires Sunstone Circuits® and Joins Forces to Enhance Customer Value in the PCB Industry
American Standard Circuits (ASC) and Sunstone Circuits are excited to announce their merger, creating a dynamic partnership that will revolutionize the printed circuit board (PCB) manufacturing landscape. This strategic alliance brings numerous advantages to customers, establishing a new standard... - July 17, 2023 - ASC Sunstone Circuits
New Cutting-Edge Pricknosis Training Enhances Hypnotherapist Michael D. Milson's Expertise
Revolutionary New Techniques Taught by the UK's Bad Boy of Hypnosis Alex William Smith (aka Jonathan Royle) Will Add to Michael's Bag of Tools, and Benefit Clients in Their Weight-Loss Success. - July 14, 2023 - Michigan Hypnosis Institute, LLC
Dr. Sarah Samreen Introduces Endolumik’s Novel Fluorescent Device for Robotic Surgery
Dr. Sarah Samreen performed the first ever fluorescent guided robotic bariatric surgery, using Endolumik's new Gastric Calibration Tube. - July 13, 2023 - Endolumik, Inc.
Why Insurance Companies Are Gravitating Towards the PathFree AiCart: an In-Depth Analysis Into Its Benefits
The PathFree AiCart is causing a sensation in the healthcare and insurance sectors, and for good reasons. Let's explore how this groundbreaking technology is changing the game in patient care, cost-effectiveness, risk management, and operational efficiency. Enhanced Patient Health and Proficiency... - July 13, 2023 - PathFree Technologies Corporation
Cayman and Navinci Announce Strategic Partnership, Expanding Access to Next-Generation Tools for Spatial Proteomics
Cayman and Navinci have partnered to bring next-generation proximity ligation-based solutions for spatial proteomics to US and Canada-based researchers. - July 13, 2023 - Cayman Chemical Company
Paras Biopharma (Biologics CDMO) Announces Industry Leading Scale-up Development & Production Process of an “Onco-Immunology Fc-fusion Biologic”
Paras Biopharma (Biologics CDMO) Finland team is pleased to announce that its extensive efforts have resulted in the successful scale-up, optimization & development of a biologically-active onco-immunology, “peptide FC-fusion” biologic. - July 12, 2023 - Paras Biopharmaceuticals Finland Oy
PathFree Expansion LLC Announces Advancements Made by PathFree Technologies Corporation
PathFree Technologies Corporation, a medical device company, has developed patented devices that enhance safety and efficiency in healthcare. With a strong patent portfolio and significant market potential, the company aims to revolutionize the industry. Seeking $10M for manufacturing and operations, they project $100M in revenue by year three. The devices are poised to receive FDA clearance, offering a unique opportunity for growth in the global medical device market. - July 12, 2023 - PathFree Technologies Corporation
Foam Swab Manufacturer Super Brush LLC Will Exhibit at the AACC Annual Scientific Meeting & Clinical Lab Expo at Booth #711
Super Brush LLC, a leader in foam swab technology for over 65 years, will exhibit their technologically advanced foam swab product line in Booth #711 at the Anaheim Convention Center in Anaheim, CA, July 23-27, 2023. The American Association for Clinical Chemistry (AACC) promotes cutting edge... - July 12, 2023 - Super Brush LLC
CloudLIMS Exhibits Its Secure Clinical LIMS at the 2023 AACC Annual Scientific Meeting and Clinical Lab Expo
CloudLIMS to showcase its configurable, secure, in-the-cloud Clinical LIMS at booth 4089 during the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo. - July 12, 2023 - CloudLIMS
Bertec Unveils Expanded Distribution of Its Comprehensive Clinical Product Portfolio, Opening New Doors for Business Partners
Bertec, a leading developer, manufacturer, and provider of innovative clinical systems specializing in balance and vestibular testing, paves the way for expanded opportunities and enhanced support for valued business partners and customers worldwide. - July 05, 2023 - Bertec
Paras Biopharma (Biologics CDMO) Maximises Recombinant Protein Expression in Microbial Systems – To Facilitate Economical Scale-Up in Production of Biologics
Paras Biopharma (Biologics CDMO) Finland, a leading biopharmaceutical technology development company in the Nordic region, maximises recombinant protein expression in Microbial Systems in its fully-equipped biologics production facility in Finland. - July 04, 2023 - Paras Biopharmaceuticals Finland Oy
Brooke Chase Associates, Inc. Announces Addition of Joe Richardson as Newest Recruiter
Executive search firm, Brooke Chase Associates, Inc., is pleased to announce the addition of Joe Richardson to their executive recruiter team. - July 01, 2023 - Brooke Chase Associates, Inc.
Study Finds Non-Surgical Back Pain Treatment May Promote Cellular Healing Achieves Higher Success Rates Due to Patented Oscillation Feature
Active oscillatory signaling introduced during the high-tension period of decompression treatment may lead to higher levels of self-healing through improved tissue repair and uniform separation of the vertebrae. Videofluoroscopy imaging was used by researchers to study how the spine responds to dynamic forces during IDD Therapy® treatment, an advanced spinal decompression treatment performed with a device called the Accu-SPINA® System. - June 30, 2023 - North American Medical Corporation
Tialma's Aleksey Krylov Attending NewYorkBIO Life Science Company Showcase
Tialma, a CFO consultancy to the life science companies, is sharing that its lead consultant Aleksey Krylov will attend the highly anticipated NewYorkBIO Life Science Company Showcase, scheduled to take place on June 27, 2023. The NewYorkBIO Life Science Company Showcase is an esteemed event that... - June 27, 2023 - Tialma
Aleksey Krylov Joining Oncology Advanced Practice Forum Online Conference
Tialma, a CFO consultancy to the life science companies, is sharing that its lead consultant Aleksey Krylov will join Oncology Advanced Practice Forum Online Conference, scheduled to take place on June 26, 2023. Tialma chose this event because of its versatility, which enables networking... - June 26, 2023 - Tialma
PMC Addresses Opioid Shortages and Advocates for Patient Well-Being
The Delaware Valley is experiencing shortages of chronic pain management tools like opioids and other medications. PMC is uniquely equipped to address these dangers by helping patients avoid missed doses so they can maintain their health, avoid hospitalization, and loss of independence. The effect of shortages is particularly dangerous for patients with chronic conditions, like persistent pain, as replacement therapies are pursued. - June 24, 2023 - PMC Pharmacy
UserWise, LLC Celebrates Role in Norlase Obtaining 510(k) Clearance and CE Mark Approval
UserWise, LLC, a San Jose-based human factors consultancy, is pleased to announce its instrumental role in obtaining FDA 510(k) clearance and CE Mark approval for the Norlase ECHO™ Green Pattern Laser photocoagulator. UserWise began working with Norlase in 2018 to develop and execute the... - June 23, 2023 - UserWise, LLC
AOTCO Metal Finishing Acquires Modern Metal Finishing
AOTCO Metal Finishing, a Massachusetts-based national leader in electroplating, anodizing, and other surface finishing services, announced its strategic acquisition of Connecticut-based Modern Metal Finishing (MMF), further enhancing AOTCO's portfolio with MMF's expert anodizing services. This allows AOTCO to better service customers in New York, Connecticut, New Jersey and Pennsylvania. AOTCO is NADCAP and ISO 13485 accredited, ITAR registered, and serves North America's advanced manufacturers. - June 22, 2023 - AOTCO Metal Finishing
Alventa Pharma Pvt. Ltd. Introduces Affordable Generic Pharmaceutical Drugs and Extends Contract Manufacturing Services
India-based Alventa Pharma, a leading third party manufacturing pharma, is excited to announce the launch of their cost-effective generic drugs in both domestic and international markets. Alongside being Third party manufacturing pharma, Alventa Pharma now expands its services as a contract... - June 21, 2023 - Alventa Pharma Limited
PharmStars Announces Spring 2023 Accelerator Graduates: 13 Digital Health Startups Complete PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces that 13 startups have graduated from its Spring 2023 program focused on “Innovations in Women’s Health or Health Equity.” The graduating startups successfully completed PharmaU, PharmStars’ 10-week program. PharmaU culminated with a Showcase Event, held in Boston in May, that brought together the participating startups and PharmStars’ innovation-minded pharma members. - June 20, 2023 - PharmStars
ALPCO Receives FDA 510(k) Clearance for the Calprotectin Immunoturbidimetric Assay
American Laboratory Products Company, Ltd. ("ALPCO"), a global provider of specialty diagnostic solutions, today announced recent FDA 510(k) clearance of its Calprotectin Immunoturbidimetric Assay. The Calprotectin Immunoturbidimetric (IT) Assay is now IVDD and 510(k)-cleared for in... - June 15, 2023 - ALPCO
SunMed Selected to Exhibit SolidAIRity Flex® Oral Endotracheal Tube Stabilization Device at Vizient Innovative Technology Exchange
SunMed has been selected to exhibit the SolidAIRity Flex® Oral Endotracheal Tube Stabilization Device at the Vizient Innovative Technology Exchange. Vizient, Inc, the nation’s largest member-driven healthcare performance improvement company, will hold the Exchange on Oct. 3 in Grapevine,... - June 10, 2023 - Securisyn Medical
Nebraska Medicine’s Doctor Corrigan McBride First to Introduce Endolumik’s New "Safer Technology" Surgical Tool
Medical Technology company, Endolumik, launches sales of "Safer Technology" surgical device with Nebraska Medicine Bariatrics Center. - June 09, 2023 - Endolumik, Inc.
PharmStars Announces “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface” Theme for its Fall 2023 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, is accepting applications for its Fall 2023 cohort around the theme “Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.” The cohort is open to startups with digital health solutions that pharma can use to innovate therapeutic supply chain management, medication delivery, or the patient-drug experience for small molecules, biologics, or advanced therapies. Applications are due July 10, 2023. - June 06, 2023 - PharmStars
GenInvo Part of PHUSE US Connect & Informa Connect Clinical Data Disclosure, Transparency & Plain Language Summaries Event - 2023
GENINVO was a part of 2 recent global events for the life science industry. The first was "PHUSE US Connect 2023" which was held in Renaissance Orlando at SeaWorld Florida on 5th – 8th March 2023 and the second event, Informa Connect Clinical Data Disclosure, Transparency &... - June 05, 2023 - GenInvo, Inc.
Opening New Frontiers in Oral Care and the Cannabinoid Market
A groundbreaking patent has been unveiled, presenting a revolutionary method for the prevention and treatment of dental pulp-associated diseases using a cannabinoid-based composition. This patent offers pharmaceutical companies a unique opportunity to enter the rapidly growing cannabinoid market while addressing critical dental care needs. - June 04, 2023 - CannIBite
Eminent Spine’s 3D Titanium Lumbar Interbody Fusion Systems, PLIF/TLIF/ALIF, Received US-FDA 510(k) Clearance as of May 15, 2023
Eminent Spine’s 3D Lumbar Interbody Fusion Systems (PLIF, TLIF and ALIF) are offered as non-sterile. - June 02, 2023 - Eminent Spine
ThoroughCare Expands to New Location to Support Continued Operational Growth, Hiring
Expansion offers opportunities for new partnerships, product expansion. - June 02, 2023 - ThoroughCare
International Rett Syndrome Foundation (IRSF) Partners with mejo to Build Digital Caregiver Tool
My Rett Ally, a web application powered by mejo, will be specifically designed for Rett syndrome patients and families to organize and share medical information tailored to their unique journey. - June 02, 2023 - mejo
New Research Benchmarks Biopharmaceutical Perceptions of Global CRO Thought Leadership
Landmark Research Analyzes Perspectives of US and EU Biopharma C-Suite, Clinical Operations and Medical/Regulatory Affairs Professionals on Global CRO Thought Leadership. - June 01, 2023 - Life Science Strategy Group, LLC
Huntington Study Group Announces Call for Abstracts for 30th Annual Meeting
The Huntington Study Group (HSG), with a mission of accelerating treatments that make a difference for those impacted by Huntington’s disease, together with its wholly owned subsidiary, HSG Clinical Research, Inc., a world leader in conducting clinical trials for Huntington’s disease... - June 01, 2023 - Huntington Study Group
TwitchView® Train of Four Monitor Used to Eliminate Residual Neuromuscular Blockade
ASA guideline first author Dr. Stephan Thilen et al. reports exciting results from a protocol that completely eliminated post-operative residual neuromuscular blockade (PRNMB). Of note, Thilen et al. achieved this groundbreaking advance in patient safety using the TwitchView® Train of Four (TOF) monitor while maintaining a role for neostigmine as a reversal strategy, resulting in pharmacologic cost savings of $42 per patient. - May 30, 2023 - Blink Device Company
OPTI•MIST® Introduces Innovative Organic Personal Care Products
OPTI•MIST® Organic Introduces Innovative Organic Personal Care Products Infused with a Powerful Mineral-Based Antiseptic for Enhanced Hygiene. OPTI•MIST, a pioneering brand in the personal care industry, is pleased to announce the launch of its revolutionary line of organic personal... - May 26, 2023 - OPTI-LAB INC.
The Inc. Magazine, USA Includes Paras Biopharma (Biologics CDMO) as One of the Top 10 Most Innovative Biotech Companies to Follow in 2023
Paras Biopharma (Biologics CDMO), a biopharmaceutical technology development company is pleased to be included by The Inc. Magazine, USA as “One of the Top 10 Most Innovative Biotech Companies to Follow in 2023.” The Inc. Magazine serves as an online "go-to" informative tool for business leaders and entrepreneurs, including CEOs and owners of small-to-midsize companies to success, providing news, advice, and inspirational articles. - May 19, 2023 - Paras Biopharmaceuticals Finland Oy
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine
Neurocrine Biosciences Announces Publication of Full KINECT™-HD Phase 3 Study Results of Valbenazine for the Treatment of Chorea Associated with Huntington’s Disease in The Lancet Neurology. - Statistically Significant Improvement in Chorea Associated with Huntington’s Disease... - May 19, 2023 - Huntington Study Group
Complimentary Webinar: Protecting Your Lab Data? Use LIMS Security Features
Join the complimentary webinar on May 24, 2023, at 10:00 AM PDT to learn how you can protect your lab data from cyberattacks using the security features of a Laboratory Information Management System (LIMS). - May 19, 2023 - CloudLIMS
PharmStars Announces Spring 2023 Startup Showcase Event Underway
PharmStars, the pharma-focused accelerator for digital health startups, announces that its fourth Showcase Event begins May 16, 2023. The Showcase is the culmination of the Spring 2023 10-week accelerator program. At the Showcase, each startup in the fourth cohort makes a formal presentation to and meets individually with PharmStars’ pharma members. The theme of the Spring 2023 program is digital innovations in women’s health or health equity. - May 16, 2023 - PharmStars
Huntington Study Group Achieves Last Patient Last Visit for Its Observational Study to Test Virtual Use of the Unified Huntington’s Disease Rating Scale®
The Huntington Study Group (HSG) together with its wholly owned subsidiary, HSG Clinical Research, Inc., announces an important milestone in the novel observational study Virtual Unified Huntington’s Disease Rating Scale (vUHDRS™). The last participant completed the last visit, marking... - May 16, 2023 - Huntington Study Group
Leixir Dental Group Announces Strategic Partnership with Care 1st Dental Institute
Partnership expands Leixir’s clinical education, training and lab production capabilities within Texas, while also providing Care 1st a national platform for their clinical education via Leixir’s centers of excellence. - May 15, 2023 - Leixir Dental Group
LAST Skincare Unveils Upgraded Skin Repair Serum with 35+ Potent Ingredients for Profound Skin Regeneration
LAST Skincare, the brand known for its uncompromising approach to delivering clinically proven formulations that regenerate and restructure the skin, has launched an upgraded version of its signature Skin Repair Serum after two years of further research and testing. The new formula boasts 35+ plant and science-based active ingredients, including botanical alternatives to retinol, adaptogens, biomimetic tetrapeptides and peptides, cold-pressed oils, glycerides, vitamins, bioferments and more. - May 15, 2023 - LAST Skincare
Partnership Between Smiles First Corporation and Operation Smile
Smiles First Corporation and Operation Smile are pleased to announce their partnership to help the world smile a little more. Smiles First Corporation is a leading healthcare company that provides consistent services in the practice community, dental supplies, and an educational platform and is... - May 11, 2023 - Smiles First Corporation
GenRocket Launches Distributed Self-Service Platform for Synthetic Test Data Automation
New platform combines the industry’s most extensive synthetic data generation functionality with production data masking and subsetting to create a single platform for any kind of test data provisioning - May 10, 2023 - GenRocket, Inc.
Parvus Therapeutics Announces a Publication Describing the Cellular Origin of Treg Cells Generated Endogenously by Navacim Therapy
Parvus Therapeutics announced today the publication of data showing that peptide-MHC class II-coated nanoparticles (Navacims) operate by triggering the expansion of cognate T follicular helper (TFH) cells. - May 09, 2023 - Parvus Therapeutics U.S., Inc.
HerdmanHealth Announces Addition of ASI and ASI-LITE Assessments to Its Software
HerdmanHealth, a healthcare tech company, now offers the Addiction Severity Index (ASI) and ASI-LITE assessments for counselors and psychologists. ASI evaluates substance use disorders in individuals, while ASI-LITE is a quick screening tool. Their platform completes the assessments 30% faster than paper-based methods. - May 05, 2023 - HerdmanHealth Inc.
Joseph McElmeel, Chairman and CEO of Brooke Chase Associates, Inc. Attended KCMA’s 67th Annual Spring Leadership Conference
Each year, KCMA members gather for this high-caliber KCMA Annual Convention and Leadership Conference. - May 05, 2023 - Brooke Chase Associates, Inc.
Micro Merchant Systems Wins Stevie Award® for Outstanding Product Innovation in the 2023 American Business Awards®
Micro Merchant Systems, Inc., developer of the PrimeRx™ pharmacy technology management system, has been recognized for “Achievement in Product Innovation” and awarded a bronze Stevie® Award in the 2023 American Business Awards® competition. - May 04, 2023 - Micro Merchant Systems
CareSmartz is All Set to Discover the Future of Care at the HCAW Annual Spring Conference
CareSmartz360 is an all-in-one home care software to support agencies' diverse needs, empowering them to achieve greatness in their operations. CareSmartz360 has advanced features like Scheduling, Electronic Visit Verification, Billing & Payroll, HR, Marketing, and Training to help agencies experience increased ROI, profitability, and compliance on the go and assist them in effectively sailing through the challenges posed by the changing home care landscape. - May 02, 2023 - Caresmartz, Inc.
New Traceable Opioid Material® Kit Expands Coverage to Other Emerging Drugs of Concern in Seized Samples and Toxicological Casework
Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. - April 30, 2023 - Cayman Chemical Company
Liberum Independent Medical Education Announces Management Buyout
Liberum Independent Medical Education, provider of independent medical education (IME) to healthcare professionals worldwide, has announced a management buyout (MBO) from its original owner, OHC London Holdings Ltd. The MBO was led by the company's Managing Director, Celeste Kolanko who has taken ownership of the company which now operates as Liberum IME BV, and Liberum Independent Medical Education Ltd. - April 29, 2023 - Liberum Independent Medical Education Ltd
Zymeda Provider Solutions Appoints Debra Myers-Adams as Director of Client Growth & Strategy
Zymeda Provider Solutions, a leading provider of healthcare revenue cycle management solutions, announced the appointment of Debra Myers-Adams as Director of Client Growth & Strategy. This addition to the leadership team is expected to drive business growth and enhance the overall strategy of... - April 28, 2023 - Zymeda Provider Solutions